Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.290
+0.110 (5.05%)
Aug 14, 2025, 12:01 PM - Market open
Alector Employees
Alector had 238 employees as of December 31, 2024. The number of employees decreased by 6 or -2.46% compared to the previous year.
Employees
238
Change (1Y)
-6
Growth (1Y)
-2.46%
Revenue / Employee
$340,882
Profits / Employee
-$484,408
Market Cap
231.78M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 238 | -6 | -2.46% |
Dec 31, 2023 | 244 | -29 | -10.62% |
Dec 31, 2022 | 273 | 65 | 31.25% |
Dec 31, 2021 | 208 | 37 | 21.64% |
Dec 31, 2020 | 171 | 50 | 41.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALEC News
- 5 days ago - Alector, Inc. (ALEC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Alector Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call - GlobeNewsWire
- 2 months ago - Alector Provides Executive Leadership Update - GlobeNewsWire
- 2 months ago - Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Alector Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Alector to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 4 months ago - Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease - GlobeNewsWire